Explore the complete record of transactions filed by Mano Michael, Vice-Président Exécutif, Directeur Juridique et Secrétaire. Director active across 1 companies, notably Karyopharm Therapeutics Inc.. In total, 3 reports have been logged. The latest transaction was disclosed on 13 May 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
3 of 3 declarations
Michael Mano serves as Executive Vice President, Chief Legal Officer, and Secretary of Karyopharm Therapeutics Inc. He oversees the company's legal affairs and ensures regulatory compliance. With extensive experience in corporate law, he plays a key role in managing legal risks and the company's strategy. Michael Mano is committed to promoting responsible corporate governance practices.